FK
Frank Keller
Physician · Emory University School of Medicine
Credentials: · ·
History
Pediatrics
Research
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia
New England Journal of Medicine · 2014 · 1,124 citations
Journal of Clinical Oncology · 2001 · 322 citations
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma
New England Journal of Medicine · 2022 · 147 citations

33 papers

24 papers

11 papers

10 papers
- KM
9 papers
- AR
8 papers

8 papers

8 papers · 2 as a resident
Clinical trials
- 2009–2012
Study of Sirolimus With PEG-Asparaginase in Acute Lymphoblastic Leukemia (ALL)
Principal investigator · Withdrawn · Phase 1
Emory University
- 2006–2019
Principal investigator · Completed · Phase 3
Children's Oncology Group